Matches in Wikidata for { <http://www.wikidata.org/entity/Q64140187> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q64140187 description "clinical trial" @default.
- Q64140187 description "ensayu clínicu" @default.
- Q64140187 description "klinisch onderzoek" @default.
- Q64140187 description "клінічне випробування" @default.
- Q64140187 name "Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck" @default.
- Q64140187 type Item @default.
- Q64140187 label "Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck" @default.
- Q64140187 prefLabel "Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck" @default.
- Q64140187 P1050 Q64140187-89E41E81-6868-4B23-8DB7-A1A4802D88DE @default.
- Q64140187 P1132 Q64140187-FC3C770B-E868-46EA-924B-F6F0C77F1FEC @default.
- Q64140187 P1476 Q64140187-44961F2B-C62C-453C-ACCC-65C68BEDB5D4 @default.
- Q64140187 P17 Q64140187-05142AE1-BEA3-4456-9899-364C8D439D8B @default.
- Q64140187 P17 Q64140187-1609B005-9668-4D1A-B28E-C76DBDC2749F @default.
- Q64140187 P17 Q64140187-1C5E4FFC-11DE-4F31-89D2-986E986D441C @default.
- Q64140187 P17 Q64140187-30801F12-B204-4DD1-AF1B-B911EA2344BC @default.
- Q64140187 P17 Q64140187-316EECA7-0EA0-4BDF-8136-6DBCE0264BF2 @default.
- Q64140187 P17 Q64140187-3B0E8E68-BF76-4F6B-A2FB-D5A0595E899C @default.
- Q64140187 P17 Q64140187-4C8EE620-1A15-4585-B6C0-16FA1158BBC5 @default.
- Q64140187 P17 Q64140187-73EE06FD-A0B4-473B-A4D8-ABC6F085215C @default.
- Q64140187 P17 Q64140187-7CF0D29C-FB16-430D-85C1-2DE1627F79CA @default.
- Q64140187 P17 Q64140187-A0919B5C-AC17-40E5-B887-53B5E4A16D0E @default.
- Q64140187 P17 Q64140187-C9B1D3B2-76B2-4F09-9D93-4E504696EB22 @default.
- Q64140187 P17 Q64140187-E5A51316-D72F-4F5E-8379-93E78E975544 @default.
- Q64140187 P17 Q64140187-F2F9FC51-D91C-4269-BA46-1C866E927ECB @default.
- Q64140187 P2899 Q64140187-CBC36DEB-10AB-421E-8D75-A4AE07B582BB @default.
- Q64140187 P3098 Q64140187-3C641720-66B6-4E34-8EDD-DEB9F3ED37CE @default.
- Q64140187 P31 Q64140187-C4E993AB-8CDA-4C80-ABC3-29C2B71A299C @default.
- Q64140187 P4135 Q64140187-03A7085A-ED94-4614-BAF7-F0C7CDFAC502 @default.
- Q64140187 P580 Q64140187-74B4EE70-FC39-4122-B578-222B80A98986 @default.
- Q64140187 P582 Q64140187-0C2EA1E2-60A4-4392-827C-051CA0096D27 @default.
- Q64140187 P6099 Q64140187-6BB90F4D-E62A-45C4-8D5E-CDD22403C187 @default.
- Q64140187 P8363 Q64140187-0886A579-20D7-4431-9C7C-D0CBBAE6BAEC @default.
- Q64140187 P1050 Q33525 @default.
- Q64140187 P1132 "+267" @default.
- Q64140187 P1476 "A Phase II, Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 Monotherapy, Tremelimumab Monotherapy, and MEDI4736 in Combination With Tremelimumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)" @default.
- Q64140187 P17 Q142 @default.
- Q64140187 P17 Q145 @default.
- Q64140187 P17 Q16 @default.
- Q64140187 P17 Q183 @default.
- Q64140187 P17 Q230 @default.
- Q64140187 P17 Q28 @default.
- Q64140187 P17 Q29 @default.
- Q64140187 P17 Q30 @default.
- Q64140187 P17 Q31 @default.
- Q64140187 P17 Q408 @default.
- Q64140187 P17 Q801 @default.
- Q64140187 P17 Q833 @default.
- Q64140187 P17 Q865 @default.
- Q64140187 P2899 "+18" @default.
- Q64140187 P3098 "NCT02319044" @default.
- Q64140187 P31 Q30612 @default.
- Q64140187 P4135 "+96" @default.
- Q64140187 P580 "2015-04-15T00:00:00Z" @default.
- Q64140187 P582 "2016-09-26T00:00:00Z" @default.
- Q64140187 P6099 Q42824440 @default.
- Q64140187 P8363 Q78089383 @default.